A core NRF2 gene set defined through comprehensive transcriptomic analysis predicts selective drug resistance and poor multi-cancer prognosis
G. Luo, H. Kumar, K. Alridge, S. Rieger, E. Jiang, E. R. Chan, A. Soliman, H. Mahdi, J. J. Letterio
The paper defines a core NRF2 gene set from transcriptomic data that predicts drug resistance and poor cancer prognosis across multiple cancer types.
bioRxiv · Apr 20, 2023Cancer Biology